Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published Date:

Abstract

OBJECTIVE: Human studies have shown the beneficial effects of probiotic microorganisms on the parameters of metabolic syndrome (MetS) and other cardiovascular risks, but to our knowledge the effect of Bifidobacterium lactis has not yet been reported. The aim of this study was to evaluate the effect of consumption of milk containing the probiotic B. lactis HN019 on the classical parameters of MetS and other related cardiovascular risk factors.

Authors

  • Luciana Jesus Bernini
    Program of Master in Dairy Science and Technology, University of North Parana-Unopar, Londrina, Parana, Brazil.
  • Andrea Name Colado Simão
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.
  • Daniela Frizon Alfieri
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.
  • Marcell Alysson Batisti Lozovoy
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.
  • Naiara Lourenço Mari
    Department of Pathology, Clinical Analysis and Toxicology, University of Londrina, Londrina, Parana, Brazil.
  • Cínthia Hoch Batista de Souza
    Program of Master in Dairy Science and Technology, University of North Parana-Unopar, Londrina, Parana, Brazil.
  • Isaías Dichi
    Department of Internal Medicine, University of Londrina, Londrina, Parana, Brazil.
  • Giselle Nobre Costa
    Program of Master in Dairy Science and Technology, University of North Parana-Unopar, Londrina, Parana, Brazil. Electronic address: gcnobre@gmail.com.